🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lara E. Davis

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

ORCID: 0000-0002-6480-1611

Also affiliated with Oregon Health & Science University, Fred Hutch Cancer Center

MedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial”.

Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial

The Lancet(2024)10.1016/s0140-6736(24)01812-9
N/A
1.4DataRank · unranked
84 citations

Karla V. Ballman, Angela Hong, Scott M. Schuetze, Andrew J. Wagner, Varun Monga +23 more

Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma

Journal of Clinical Oncology(2024)10.1200/jco.24.00020
N/A
0.869DataRank · unranked
38 citations

Noah Federman, Najat C. Daw, Peter M. Anderson, Lara E. Davis, AeRang Kim +9 more

Protein arginine methyltransferase 5 is essential for oncogene product EWSR1-ATF1-mediated gene transcription in clear cell sarcoma

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.102434
N/A
0DataRank · unranked
12 citations

Larry L. David, Lara E. Davis, Xiangshu Xiao, Bingbing X. Li

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1824
N/A
0DataRank · unranked
215 citations

Melissa Burgess, Ruth Salazar, Edwin R. Parra, Jaime Rodrigues-Canales, Vanessa Bolejack +18 more

Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0086
N/A
0DataRank · unranked
0 citations

Danielle Kirkey, Isabel Lira, Grace Hawkins, Melia Blankenfeld, Sarah J. Menashe +12 more

PRMT5 as a Novel Druggable Vulnerability for EWSR1-ATF1-driven Clear Cell Sarcoma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.23.485409
N/A
0DataRank · unranked
0 citations

Larry L. David, Lara E. Davis, Xiangshu Xiao, Bingbing X. Li

A randomized phase II study of gemcitabine (G) alone or with pazopanib (P) in refractory soft tissue sarcoma (STS).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11515
N/A
0DataRank · unranked
2 citations

Catherine Degnin, Lee D. Cranmer, Yiyi Chen, Seth M. Pollack, Jesse Tonkinson +3 more